Local promise, global leverage Investment Banking
& Equities Solutions
We are a wholly-owned subsidiary of Axis Bank, one of India's largest private-sector banks. A leading financial expert, Axis Capital aims to provide focused and customized solutions in the areas of Investment Banking and Institutional Equities.

Investment Banking

Axis Capital’s dominance in Investment Banking services comes from 37 years of market-leading activity and deep partnerships with corporates and institutional investors. Our solutions extend to:

  • M&A: we manage highly complex transactions across a swathe of sectors and sizes involving domestic and cross-border transactions
  • ECM: India’s #1 ECM Banker over the past decade, having brought more than 50 new sectors to the capital market
  • InvITs-REITs-SF: as pioneers of InvITs-REITs in India, Axis Capital has a clutch of award-winning firsts to its credit in this product
  • Private Fund Raising (PFR): Private equity firms, venture capital funds and family offices benefit fromcapital raising as well as strategic guidance and operational expertise

Institutional Research

Top-tier research from one of the largest and best quality research teams on the street. Axis Capital offers waterfront coverage of a large and growing number of exciting firms of interest to domestic and foreign institutional investors. Key differentiators:

  • Coverage depth as well as breadth
  • Alpha-generating research
  • Macro and micro focus – from prolific thematic research to channel-check series
  • Annual Report Analysis (ARA) for strategic priorities and forensic accounting insights.

Institutional Equities

A leading institutional broker with a full suite of offerings – from research to strong corporate access, cash, derivatives and electronic trading. Axis Capital is the preferred partner for institutional investors. Highlights:

  • Strong relationships with >500 leading institutional investors across India, US, Europe, Far East and the Middle East
  • Comprehensive suite of execution services across cash and derivatives with high touch and electronic trading capability
  • Access to unique pools of liquidity across large and mid-market segments.
  • Insights

    • testing aug: aug test...

      short desc...

    • Test report: Test title...

      test short desc...

    • test: test...

      new...

  • ACL in the Media

    • Market Predictions for Budget 2025: Expert Insights from Neelkanth Mishra
    • Gaurav Malhotra:RIL Posts Strong Operating Performance In Q3 Driven By Good Shows From Retail, O2C & Jio Platforms
    • Street Signs Asia with Tanvir Gill
    • Mapping The Macros
    • CNBC TV18
  • Awards

    • 2026

      test award 2026

      By: Testi Money
    • 2019

      Most Innovative Investment Bank (Asia Pacific)

      By: The Banker
    • 2024

      India’s Best Investment Bank

      By: Asiamoney Award
    • 2024

      "Best Investment Bank Best Securities House in India"

      By: Euromoney Securities Houses Awards
    • 2024

      Best Investment Bank | Domestic

      By: Finance Asia Achievement Awards

Transactions

  • Transaction Image
    Lenskart Solutions
    Limited
    900 Mn

    IPO Nov 2025

  • Transaction Image
    LG Electronics India LTD
    999 Mn

    XYZ Nov 2025

  • Transaction Image
    Test PVT Ltd
    2,000 Mn

    test page Nov 2025

  • Transaction Image
    LG Electronics
    500 Mn

    IPO Nov 2025

  • Transaction Image
    Cholamandalam Investment
    And Finance Company
    Limited
    100 Mn

    IPO Jul 2025

  • Transaction Image
    Hindustan Zinc Ltd
    5,334 Mn

    OFS(SE) Nov 2024

  • Transaction Image
    Himatsingka Seide Ltd
    400 Mn

    QIP Oct 2024

  • Transaction Image
    Waaree Energies Ltd.
    4,321 Mn

    IPO Oct 2024

  • Transaction Image
    Cochin Shipyard Ltd.
    2,011 Mn

    OFS(SE) Oct 2024

  • Transaction Image
    Waaree Energies Limited
    43,210 Mn

    IPO Oct 2024

  • Transaction Image
    Samvardhana Motherson
    International Ltd.
    6,438 Mn

    QIP Sep 2024

  • Transaction Image
    Akums Drugs &
    Pharmaceuticals Ltd.
    1,857 Mn

    IPO Jul 2024


Testimonials

Insights Details

  • December 10, 2024

    IT Services: GenAI – millennium shapeshifter to transform services

    GenAI–our word of the year–could generate 20-40% savings in the software development lifecycle. We see no risk to tech spends with these savings being ploughed back into innovative tech for better business. Prospective TAM and margin gains make us ask – is Services as a Software the new SaaS?

  • December 10, 2024

    IT Services: GenAI – millennium shapeshifter to transform services

    GenAI–our word of the year–could generate 20-40% savings in the software development lifecycle. We see no risk to tech spends with these savings being ploughed back into innovative tech for better business. Prospective TAM and margin gains make us ask – is Services as a Software the new SaaS?

  • December 10, 2024

    IT Services: GenAI – millennium shapeshifter to transform services

    GenAI–our word of the year–could generate 20-40% savings in the software development lifecycle. We see no risk to tech spends with these savings being ploughed back into innovative tech for better business. Prospective TAM and margin gains make us ask – is Services as a Software the new SaaS?

© All rights reserved by Axis Capital 2025.